Susan Pedersen

Computer ScienceSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection”.

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

Annals of Internal Medicine(2023)10.7326/m22-2381

N/A

2.0DataRank · unranked

63 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +41 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01254-1

N/A

1.6DataRank · unranked

53 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +51 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Annals of Internal Medicine(2023)10.7326/m22-3428

N/A

0.785DataRank · unranked

31 citations

Kara W Chew, Mark J Giganti, Carlee Moser, Mauricio Pinilla, David A. Wohl +76 more

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad342

N/A

0.622DataRank · unranked

19 citations

Kara W Chew, Mark J Giganti, Eric S. Daar, David A. Wohl, Arzhang Cyrus Javan +47 more

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy

Open Forum Infectious Diseases(2024)10.1093/ofid/ofad694

N/A

0.553DataRank · unranked

14 citations

Ronald J. Bosch, Ashley McKhann, Raymond Cha, Gene D. Morse, Chanelle Wimbish +28 more

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.10039

N/A

0.490DataRank · unranked

11 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +47 more

The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy

The Journal of Infectious Diseases(2024)10.1093/infdis/jiad423

N/A

0.483DataRank · unranked

13 citations

Patrick J. Hanley, Shane D. Falcinelli, JoAnn Kuruc, Susan Pedersen, Jennifer Kirchherr +16 more

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae369

N/A

0.165DataRank · unranked

2 citations

Babafemi Taiwo, Carlee Moser, Eric S. Daar, David A. Wohl, Justin Ritz +46 more

The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy

UNC Libraries(2025)10.17615/shqb-1g34

N/A

0DataRank · unranked

0 citations

JoAnn Kuruc, Jennifer Kirchherr, Cecilia M. Motta, Nilu Goonetilleke, Chris Lazarski +16 more

Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101745

N/A

0DataRank · unranked

9 citations

Ronald J. Bosch, Catherine Godfrey, Hanna Mar, Apsara Nair, Michael C. Keefer +28 more

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102787

N/A

0DataRank · unranked

3 citations

Carlee Moser, Nikolaus Jilg, Justin Ritz, David A. Wohl, Jonathan Z. Li +89 more

Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae501

N/A

0DataRank · unranked

0 citations

Brooke McGinley, Carlee Moser, Jonathan Z. Li, Teresa H. Evering, Justin Ritz +42 more

A Video Game For Enhancing Learning In Digital Systems Courses

(2020)10.18260/1-2--4906

N/A

0DataRank · unranked

2 citations

V. Srinivasan, Susan Pedersen, Karen L. Butler-Purry